
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.370 | 2.470 | 0.100 |
Shares | 97.630 | 97.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.340 | 23.155 |
Price to Book | 3.864 | 4.598 |
Price to Sales | 1.740 | 3.499 |
Price to Cash Flow | 13.550 | 15.854 |
Dividend Yield | 1.602 | 1.282 |
5 Years Earnings Growth | 11.219 | 11.639 |
Name | Net % | Category Average |
---|---|---|
Technology | 23.190 | 27.797 |
Financial Services | 18.890 | 14.917 |
Healthcare | 14.590 | 14.603 |
Consumer Cyclical | 11.100 | 12.541 |
Communication Services | 10.650 | 8.922 |
Industrials | 7.310 | 12.244 |
Consumer Defensive | 4.760 | 6.158 |
Real Estate | 4.560 | 1.772 |
Energy | 3.900 | 2.690 |
Basic Materials | 1.050 | 3.734 |
Number of long holdings: 84
Number of short holdings: 8
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 3.76 | 212.93 | +1.02% | |
NVIDIA | US67066G1040 | 3.59 | 129.93 | +5.63% | |
Amazon.com | US0231351067 | 3.48 | 211.37 | +1.31% | |
Microsoft | US5949181045 | 2.75 | 449.14 | -0.03% | |
Taiwan Semicon | TW0002330008 | 2.25 | 957.00 | +0.00% | |
Mastercard | US57636Q1040 | 2.21 | 576.59 | -0.29% | |
Alphabet C | US02079K1079 | 2.08 | 160.89 | +0.82% | |
Eli Lilly | US5324571083 | 2.06 | 746.06 | -1.26% | |
Allianz | DE0008404005 | 2.04 | 350.90 | -0.23% | |
Cencora Inc | US03073E1055 | 1.99 | 279.00 | +0.22% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1804833579 | 282.76M | -3.11 | 3.91 | - | ||
LU1892389757 | 216.26M | -10.54 | -0.79 | - | ||
LU2114785194 | 197.2M | -7.47 | 2.40 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review